SUMMARY Antibodies to synthetic 3H-poly dAT have the advantage over antibody to native DNA in that they have a higher degree of specificity for systemic lupus erythematosus (SLE). This is because poly dAT eliminates the problem of measurement of single stranded antibodies that are not specific for any one condition but which may be detected by native DNA preparations which usually contain single stranded regions. The overall degree of correlation between the two antibodies is good in SLE. Antibodies to poly dAT correlate well with clinical evidence of disease activity but in this study were not particularly associated with the presence of renal disease.
It has been reported that antibodies to double stranded DNA occur exclusively in the sera of patients with systemic lupus erythematosus (SLE)'
and that the amount of antibody present correlates with disease activity and is therefore useful in both the diagnosis and therapeutic monitoring of the disease. 2 3 In subsequent reports, there has been some discrepancy in the specificity of these antibodies which has probably been due to the contamination of the native DNA used in the assay systems with either single stranded DNA or duplex DNA with single stranded regions.4-6This inevitably results in the detection of antibodies to both double stranded and single stranded DNA as well as antibodies to other non-nucleic acid antigenic contaminants. 7 The overall result has been the reports of antibodies to DNA occurring in a wide number of connective and chronic inflammatory diseases.
One attempt at solving this problem was to filter native DNA using a nitrocellulose filter, since these filters of 045 pm pore size retain both single stranded DNA and protein-n-DNA complexes but allow n-DNA to pass through. to possess all, or most of, the binding sites intrinsic to naturally occurring DNA, because the antigenic sites responsible for binding anti-n-DNA are located on the exposed deoxyribose-phosphate backbone and are independent of the individual bases. '2 Poly dAT, therefore, provides a uniform and completely double stranded antigen that could be used in the detection of antibodies which react specifically with duplex DNA. This study reports results using this antigen with a standard radioimmunoassay in 923 serum samples from patients with a variety of connective tissue diseases. In addition, the correlation between antibodies to poly dAT was compared to antibodies to a well characterised native DNA preparation in 398 serum samples from patients with SLE.
The results of poly dAT binding were also correlated with disease activity in 37 patients from whom multiple samples had been obtained over a variable time course.
Material and methods
Sera from a total of 195 non-laboratory controls, 65 patients with Crohn's disease, 20 patients receiving haemodialysis, 398 samples from 107 patients with SLE, and 245 samples from patients with other connective tissue diseases were tested for antibodies to native DNA and poly dAT using the Millipore Filter Assay.
In the case of the sera from patients with SLE, a comparative study of binding to both poly dAT and a well characterised native DNA preparation was performed. In 37 cases of SLE, all of whom ful-filled the Arthritis and Rheumatism Association preliminary criteria for the classification of the disease, serial levels of poly dAT binding were correlated with clinical evidence of disease activity.
DISEASE ACTIVITY
Clinical evidence of disease activity was assessed by the presence of currently active clinical signs or symptoms and independently of knowledge of levels of DNA and poly dAT antibodies and complement levels. Emphasis was placed on the presence of an actively changing clinical picture rather than evidence of previous but currently quiescent disease. The following variables were assessed: skin rash, mouth ulcers, increased hair loss, synovitis, pleurisy, pericarditis, serositis, myositis, deteriorating CNS involvement, deteriorating renal function. In addition, patients were divided into renal and non-renal groups. Twenty-two patients were included in the renal group and had either biopsy evidence of active renal disease (11 patients) or an active urinary sediment (cellular casts and proteinuria > 500 mg/24 h). The remaining 15 patients had no clinical evidence of renal disease.
MILLIPORE FILTER ASSAY13
In the binding assay procedure, 100 [l 3H-poly dAT, 0-532 ,ug/ml, in citrate buffer, pH 7 0, were added to 25 ,ul heat inactivated serum in 12 x 75 mm glass tubes. Blanks, consisting of 100 pI 3H-poly dAT and 25 pl citrate buffer were included with each individual run. The mixture was incubated at 37°C for 15 minutes, and the reaction was then stopped by adding 4 ml cold citrate buffer, pH 8 0. The diluted mixture was passed through pre-wet HAWP Millipore filters (pore size 0 45 /im) using gentle vacuum. Both the reaction tubes and the filter were washed twice with 4 ml citrate buffer and once with 4 ml distilled water. The filters were then placed in glass scintillation vials and dried. Upon drying, 10 ml DPO toluene scintillation fluid was added. The samples were counted in a liquid scintillation counter. The binding serum was determined by taking the number of counts in the sample, subtracting the number of counts in the blank, and dividing by the total number of counts in 100 pl 3H-poly dAT. Results were expressed as a percentage.
3H-POLY dAT SYNTHESIS
The 3H-poly dAT employed in this study was prepared by combining 1-25 ml of I10 M KPi (10 M KH2PO2 adjusted to pH 75 with 100 M KOH), 0 50 ml 0-1 M MgCl2, 50 Hul 01 M deoxyadenosine 51 triphosphate, 2 5 ml 2mM 3H thymidine 51 triphosphate (15 000 cpm/nmol), 150 ,l DNA polymerase 1, 20-3 ml distilled H20, and 250 ,iA poly dAT (13 4 A260) together in a glass 13 x 100 mm tube. The mixture was incubated at 37°C and checked hourly on a Turner model 430 spectrofluorometer by the ethidium bromide assay.14 When the 3H-poly dAT fluorescence reached a peak the reaction was stopped by immersing the poly dAT mixture in a 950 waterbath for 5 minutes.
The poly dAT was then concentrated in a cellodian bag to 1 0 ml and run over a 0 5 mol/l agarose column to be purified.
After purification, the 3H-poly dAT was diluted to the desired storage concentration with 10 mM Tris 0 1 mM EDTA, pH 8-0, and stored at -20°C.
The 3H-poly dAT used in the study was tested for double stranded purity by the ethidium fluorescence technique which indicated a 100% duplex structure.
NATIVE DNA
In this study an Escherichia coli DNA was used (kindly provided by Wampole Labs, Cranbury, New Jersey, USA). This preparation was labelled with 125I and found to be 85% duplex in structure using the ethidium bromide assay.
Results
The number of sera which bound to the native DNA preparation and the poly dAT are tabulated in Table 1 Table 2 . The overall degree of correlation is good but is less so in those sera that contained abnormally high levels of antibody to one or other antigen. This was predominantly due to sera that bound only to the native DNA but not to the poly dAT, sometimes in high titre. As the native DNA is known to contain single stranded regions, this probably reflects binding by single stranded antibody which is not detected by the entirely duplex poly dAT.
Levels of DNA antibody appear from previous studies to correlate well with clinical evidence of disease activity in SLE.24 From our study the same also appears to be true for antibodies to poly dAT. There was a significant correlation between the presence of antibodies to poly dAT and clinical evidence of disease activity. This was true of all patients whether renal disease was present or not. These results are in contrast to those reported by Steinman et al.,25 who showed a significant correlation between poly dAT binding and renal histology. The probable explanation for this apparent discrepancy is that fewer of our patients were subjected to renal biopsy and histological assessment. It is possible, therefore, that some of our patients in the non-renal groups with elevated poly dAT binding may well have had abnormal renal histology if biopsy had been performed even though there was no clinical evidence of renal disease as assessed by active urinary sediment or proteinuria.
The value of poly dAT lies in its homogeneous character and its lack of single stranded regions. It would be of value in interlaboratory standardisation and would overcome some of the discrepancies reported, due to the considerable differences in size, structure, and source of native DNA preparations currently used. In our experience, it is more specific for SLE than native DNA and can be used equally well for serial monitoring of disease activity.
